Results 81 to 90 of about 21,395 (260)

Pseudohypoparathyroidism type I-b with neurological involvement is associated with a homozygous PTH1R mutation [PDF]

open access: yes, 2016
Pseudohypoparathyroidism type 1b (PHP1b) is characterized by hypocalcemia, hyperphosphatemia, increased levels of circulating parathyroid hormone (PTH), and no skeletal or developmental abnormalities.
Almeida, MR   +8 more
core   +1 more source

Central Diabetes Insipidus in Suprasellar Germ Cell Tumor Paradoxically Presenting With Oliguria

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Central diabetes insipidus may present as oliguric acute kidney injury (AKI), particularly in patients with communication difficulties. While polyuria is common in AKI recovery, persistent or unexplained hypernatremia should prompt suspicion for alternative diagnoses such as unmasked diabetes insipidus to ensure timely recognition and ...
Karen Kin Nam Wong   +2 more
wiley   +1 more source

Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease [PDF]

open access: yes, 2012
Background: Uremic solute concentration increases as Glomerular Filtration Rate (GFR) declines. Weak associations were demonstrated between estimated GFR (eGFR) and the concentrations of several small water-soluble and protein-bound uremic solutes ...
Barreto, Daniela V   +9 more
core   +5 more sources

Renoprotective Effect of Coix lachryma‐jobi L. Seed Polysaccharides in Adenine‐Induced Chronic Renal Failure by Blocking Gut Urea Metabolism

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
ABSTRACT Dietary soluble fiber may alleviate renal damage in chronic kidney disease (CKD) by promoting intestinal urea excretion, though the underlying mechanisms remain unclear. This study investigated the digestion, fermentation, and renoprotective effects of Coix lachryma‐jobi L.
Hongmei Yin   +9 more
wiley   +1 more source

Efficacy and safety offerric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease:a Meta-analysis

open access: yesLinchuang shenzangbing zazhi, 2020
Objective To evaluate the efficacy and safety of ferric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease(CKD),and provide evidence-based basis for clinical medication.Methods The literature on randomized controlled trials(
WANG Shan-shan, WEN Tong, ZHANG Xin-zhou
doaj  

Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients [PDF]

open access: yes, 2013
BACKGROUND: Hyperphosphatemia has been implicated in the development and treatment of various cancers. However, whether it can be used as a direct prognostic marker of colorectal cancer (CRC) has remained unexplored.
Guiles, Fran   +8 more
core   +1 more source

Fatal Tumor Lysis Syndrome Induced by Pembrolizumab in Advanced Renal Pelvis Cancer

open access: yesIJU Case Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Introduction Tumor lysis syndrome (TLS) arises from the rapid breakdown of tumor cells during oncological treatment. Although TLS is rarely observed in solid tumors, few studies have documented instances of TLS associated with pembrolizumab. This report presents a case involving pembrolizumab‐induced TLS.
Takashi Asakura   +3 more
wiley   +1 more source

Unveiling Surfactant‐Coated Iron Oxide Nanoparticle Specifications for Enhancing Phosphate Removal in Peritoneal Dialysis‐Simulating Conditions

open access: yesSmall Structures, Volume 7, Issue 1, January 2026.
To enhance phosphate removal during peritoneal dialysis, a new dialysate formulation with designed surfactant‐coated iron oxide nanoparticles has been shown to be very effective through experiments in laboratory‐scale dialysis setups. Several transport mechanisms, including electrodiffusion and the Gibbs–Donnan effect, have been evidenced, providing ...
Théo Lucante   +4 more
wiley   +1 more source

Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration [PDF]

open access: yesТерапевтический архив, 2018
Aim of the study was to explore the role of the FGF-23/sKlotho/sclerostin ratio disturbance in the determining of cardiovascular risk in end stage renal disease (ESRD) patients, receiving treatment with regular hemodialysis (НD) or hemodiafiltration (НDF)
L Yu Milovanova   +7 more
doaj   +1 more source

Osteitis Fibrosa Cystica: An Unusual Cause of Left‐Sided Chest Pain

open access: yesCase Reports in Nephrology, Volume 2026, Issue 1, 2026.
We report a case of osteitis fibrosa cystica resulting from secondary hyperparathyroidism in a 21‐year‐old male patient with end‐stage renal disease. The patient presented with persistent, moderate chest pain localized to the left fifth and sixth ribs for eight months. A chest X‐ray revealed well‐defined, expansile lytic lesions in these ribs.
Raahima Habib   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy